This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 Sep 15:733:46-55.

doi: 10.1111/j.1749-6632.1994.tb17255.x.

Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival

K Oberg¹

Affiliations

PMID: 7978895
DOI: 10.1111/j.1749-6632.1994.tb17255.x

Review

Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival

K Oberg. Ann N Y Acad Sci. 1994.

. 1994 Sep 15:733:46-55.

doi: 10.1111/j.1749-6632.1994.tb17255.x.

Author

K Oberg¹

Affiliation

¹ Department of Internal Medicine, University Hospital, Uppsala, Sweden.

PMID: 7978895
DOI: 10.1111/j.1749-6632.1994.tb17255.x

No abstract available

PubMed Disclaimer

Similar articles

Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
Özaslan E, Bayram F, Karaca H, Gürsoy Ş, Öztürk F, Sözüer E, Abdurrezzak Ü, Yurci A, Can Sezgin G, Yıldırım A, Başpınar O, Kula M, Özkan M. Özaslan E, et al. Turk J Gastroenterol. 2016 Nov;27(6):509-514. doi: 10.5152/tjg.2016.16391. Turk J Gastroenterol. 2016. PMID: 27852541
Neuroendocrine tumours: clinical presentation and management of localized disease.
Kulke MH. Kulke MH. Cancer Treat Rev. 2003 Oct;29(5):363-70. doi: 10.1016/s0305-7372(03)00072-0. Cancer Treat Rev. 2003. PMID: 12972355 Review.
Prognostic impact of DNA-image-cytometry in neuroendocrine (carcinoid) tumours.
Petersen I. Petersen I. Cell Oncol. 2006;28(3):117-8; author reply 119-20. doi: 10.1155/2006/754730. Cell Oncol. 2006. PMID: 16823180 Free PMC article. No abstract available.
Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ, Salem RR. Kuo EJ, et al. Ann Surg Oncol. 2013 Sep;20(9):2815-21. doi: 10.1245/s10434-013-3005-7. Epub 2013 Jun 15. Ann Surg Oncol. 2013. PMID: 23771245
Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O. Rorstad O. J Surg Oncol. 2005 Mar 1;89(3):151-60. doi: 10.1002/jso.20179. J Surg Oncol. 2005. PMID: 15719376 Review.

See all similar articles

Cited by

Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis.
Grabowski P, Sturm I, Schelwies K, Maaser K, Buhr HJ, Dörken B, Zeitz M, Daniel PT, Scherübl H. Grabowski P, et al. Int J Colorectal Dis. 2006 Apr;21(3):221-30. doi: 10.1007/s00384-005-0779-5. Epub 2005 Jun 14. Int J Colorectal Dis. 2006. PMID: 16485142
Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.
Lim CH, Lee IS, Jun BY, Kim JS, Cho YK, Park JM, Roh SY, Lee MA, Kim SW, Choi MG. Lim CH, et al. Korean J Intern Med. 2017 May;32(3):452-458. doi: 10.3904/kjim.2015.232. Epub 2016 Mar 29. Korean J Intern Med. 2017. PMID: 28490723 Free PMC article.
Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract: A case report.
Pirozzi A, Riccardi F, Arpino G, Mocerino C, Campione S, Molino C, Cartenì G. Pirozzi A, et al. Medicine (Baltimore). 2019 Jul;98(29):e16508. doi: 10.1097/MD.0000000000016508. Medicine (Baltimore). 2019. PMID: 31335724 Free PMC article.
Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors.
Stilling GA, Zhang H, Ruebel KH, Leontovich AA, Jin L, Tanizaki Y, Zhang S, Erickson LA, Hobday T, Lloyd RV. Stilling GA, et al. Endocr Pathol. 2007 Winter;18(4):223-32. doi: 10.1007/s12022-007-9001-3. Endocr Pathol. 2007. PMID: 18247165
Second primary malignancies in patients with neuroendocrine tumors.
Reina JJ, Serrano R, Codes M, Jiménez E, Bolaños M, Gonzalez E, Sevilla I. Reina JJ, et al. Clin Transl Oncol. 2014 Oct;16(10):921-6. doi: 10.1007/s12094-014-1174-x. Epub 2014 May 1. Clin Transl Oncol. 2014. PMID: 24788817

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information